Cell Impact AB (CI) AI Stock Analysis

• Market Cap: kr91.32M
• Dividend Yield: N/A
• Average Volume (3M): 4.50M
• Price to Earnings (P/E): ―
• Beta (1Y): 1.82
• Revenue Growth: -81.35%
• EPS Growth: 42.35%
• Country: SE
• Employees: 41
• Sector: Industrials
• Sector Strength: 72
• Industry: Manufacturing - Metal Fabrication
• EPS (TTM): -0.14
• Shares Outstanding: 294,584,750
• 10 Day Avg. Volume: 6,494,872
• 30 Day Avg. Volume: 4,501,845
• PEG Ratio: 0.10
• Price to Book (P/B): 4.03
• Price to Sales (P/S): 23.68
• P/FCF Ratio: -11.53
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: Hold
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 47 Neutral
• Price Target: kr0.40 ▲(17.94% Upside)

Cell Impact AB's overall stock score is primarily impacted by its poor financial performance, characterized by significant losses and cash flow challenges. While technical analysis shows some positive trends, the negative valuation metrics further weigh down the score. The absence of earnings call insights and corporate events leaves the financial and technical aspects as the primary determinants of the stock's score.

Positive Factors

Industry Position

Cell Impact's focus on hydrogen fuel cell components positions it well in the growing renewable energy sector, offering long-term growth potential as demand for clean energy solutions increases.

Debt Management

A conservative debt approach provides financial stability and flexibility, enabling the company to navigate economic fluctuations and invest in growth opportunities without excessive financial strain.

Revenue Streams

Diverse revenue streams from OEMs and partnerships in the hydrogen sector enhance revenue stability and growth potential, aligning with increasing investments in hydrogen infrastructure.

Negative Factors

Revenue Decline

Significant revenue decline indicates challenges in market demand or operational execution, which could impact long-term financial health and require strategic adjustments to reverse the trend.

Profitability Issues

Negative profitability metrics highlight operational inefficiencies and cost management issues, necessitating strategic improvements to achieve sustainable profitability and shareholder returns.

Cash Flow Challenges

Weak cash flow position limits the company's ability to fund operations and invest in growth, posing liquidity risks that could affect long-term business sustainability and strategic initiatives.

Cell Impact AB Business Overview & Revenue Model

Company Description

Cell Impact AB (publ) manufactures and sells bipolar flow plates for hydrogen fuel cells in Sweden and internationally. The company offers plates with and precise flow patterns. It serves hydrogen fuel cells producers. The company was incorporated in 1999 and is based in Karlskoga, Sweden.

How the Company Makes Money

Cell Impact AB generates revenue primarily through the sale of its fuel cell components, particularly its proprietary bipolar plates. The company engages in contracts with manufacturers and suppliers in the automotive and energy sectors, providing them with high-quality, efficient components that are crucial for the operation of hydrogen fuel cells. Key revenue streams include direct sales to OEMs (original equipment manufacturers) and partnerships with companies in the hydrogen and fuel cell industries. Additionally, CI may benefit from research and development agreements, as well as potential collaborations with governmental and research institutions focused on advancing hydrogen technology. The growing demand for clean energy solutions and increased investment in hydrogen infrastructure further contribute to the company's earnings potential.

Cell Impact AB Financial Statement Overview

Summary

Cell Impact AB faces significant financial challenges, with declining revenues, negative profitability, and cash flow issues. The balance sheet remains relatively stable, but the company's operational inefficiencies and liquidity concerns pose substantial risks. Strategic improvements in cost management and revenue generation are crucial for financial recovery.

Income Statement

Cell Impact AB's income statement reveals significant challenges, with negative net profit margins and declining revenue. The TTM data shows a drastic revenue drop of 64.75%, and gross profit margins have deteriorated significantly. The company is struggling with profitability, as indicated by negative EBIT and EBITDA margins, reflecting operational inefficiencies and cost management issues.

Balance Sheet

The balance sheet shows moderate leverage with a debt-to-equity ratio of 0.14, indicating a conservative approach to debt. However, the return on equity is negative, reflecting the company's inability to generate returns for shareholders. The equity ratio remains stable, suggesting a solid capital structure, but the negative ROE highlights profitability concerns.

Cash Flow

Cash flow analysis indicates negative operating and free cash flows, with a declining trend in free cash flow growth. The operating cash flow to net income ratio is negative, suggesting cash flow issues. Despite a positive free cash flow to net income ratio, the overall cash flow position is weak, highlighting liquidity challenges.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	6.70M	37.33M	47.26M	76.81M	71.35M	29.31M
Gross Profit	-5.30M	5.42M	25.45M	36.94M	34.88M	19.14M
EBITDA	-68.35M	-66.52M	-97.72M	-86.22M	-68.84M	-37.29M
Net Income	-104.42M	-100.43M	-121.40M	-104.22M	-79.85M	-44.26M
Balance Sheet
Total Assets	216.69M	261.25M	381.93M	401.51M	238.72M	242.88M
Cash, Cash Equivalents and Short-Term Investments	6.67M	20.39M	99.89M	164.67M	28.56M	151.93M
Total Debt	21.44M	30.92M	42.75M	44.70M	19.51M	21.98M
Total Liabilities	29.21M	42.16M	78.56M	77.17M	96.10M	40.99M
Stockholders Equity	187.48M	219.08M	303.37M	324.35M	142.63M	201.89M
Cash Flow
Free Cash Flow	-54.25M	-76.66M	-152.75M	-174.32M	-140.39M	-69.64M
Operating Cash Flow	-50.13M	-62.23M	-100.97M	-105.93M	-86.08M	-47.59M
Investing Cash Flow	100.00K	-14.43M	-51.78M	-68.40M	-54.32M	-21.96M
Financing Cash Flow	38.62M	-2.84M	88.09M	310.47M	17.01M	204.57M

Cell Impact AB Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 0.34
• 50DMA: Negative
• 100DMA: Positive
• 200DMA: Positive
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SE:CI, the sentiment is Negative. The current price of 0.34 is below the 20-day moving average (MA) of 0.39, below the 50-day MA of 0.34, and above the 200-day MA of 0.34, indicating a neutral trend. The MACD of >-0.01 indicates Positive momentum. The RSI at 44.81 is Neutral, neither overbought nor oversold. The STOCH value of 22.03 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for SE:CI.

Cell Impact AB Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	63 Neutral	$10.79B	15.43	7.44%	2.01%	2.89%	-14.66%
PCELL	52 Neutral	$2.49B	-400.56	-1.63%	―	36.59%	91.88%
TRANS	48 Neutral	€327.29M	―	0.35%	―	10.36%	-100.68%
CI	47 Neutral	kr91.32M	-0.32	―	―	-81.35%	42.35%
AXOLOT	43 Neutral	€93.98M	-9.58	-17.60%	―	-27.29%	72.72%
SALT.B	39 Underperform	€977.62M	-13.99	-40.77%	―	11.85%	6.39%
BOMILL	36 Underperform	€68.71M	―	-115.02%	―	-65.29%	-33.93%